Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. DC Vapor, Inc.
WARNING LETTER
•DC Vapor, Inc.•February 12, 2021

FDA WARNING_LETTER - DC Vapor, Inc. - February 12, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On February 12, 2021, the FDA issued a Warning Letter to Barry Vuong regarding e-liquid products sold on dcvapor.com. The FDA's Center for Tobacco Products reviewed the website and determined that e-liquid products are manufactured and offered for sale or distribution in the U.S., classifying them as tobacco products under section 201(rr) of the FD&C Act.

The letter states that certain e-liquid products, specifically Signature Series - Frujuze - Galaxy Reloaded, Signature Series - Brefest - Jax, and Pound Town - Festival, are "new tobacco products" because they were not commercially marketed in the U.S. as of February 15, 2007. These products lack the required premarket authorization order under section 910(c)(1)(A)(i) of the FD&C Act, making them adulterated under section 902(6)(A) and misbranded under section 903(a)(6) due to the absence of required information under section 905(j).

The FDA requires a written response within 15 working days detailing actions taken to address the violations, including discontinuing the violative labeling, advertising, sale, and/or distribution, and a plan for maintaining compliance. Failure to comply may result in civil money penalties, seizure, and/or injunction. The firm is a registered

Company
DC Vapor, Inc.
Inspection Date
February 12, 2021
Product Type
Tobacco
Office
Center for Tobacco Products
People
  • Ann Simoneau (Director)
  • Toan Nguyen
Open in Dashboard

ID · 82b38b01-bd86-4087-8106-894b2c4c7622

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 CFR 1100.121 U.S.C. 387j(a)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387e(j)(3)FD&C Act 902(6)(A)FD&C Act 903(a)(6)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.